Australia to Develop Foodborne Campylobacter Action Plan

Why It Matters

Cutting Campylobacter infections will reduce healthcare expenditures and protect Australia’s poultry export reputation, boosting consumer confidence in the food system.

Key Takeaways

• Campylobacter causes 60% of Australia’s foodborne illness cases
• Economic burden exceeds US $110 million annually from chicken consumption
• Five‑year Action Plan coordinates regulators, industry, researchers, and public health
• FSANZ and Safe Food Production Queensland lead the implementation sub‑committee
• Stakeholders can register now for direct input on the plan

Pulse Analysis

Campylobacter remains the leading cause of foodborne disease in Australia, responsible for roughly 28,000 cases in 2017 and representing 60 percent of all reported incidents. The pathogen’s prevalence, especially in poultry, translates into a substantial economic toll—more than US $110 million each year from chicken‑related infections alone. These figures underscore a public‑health imperative: without coordinated intervention, the burden on hospitals, lost productivity, and consumer confidence will continue to rise.

In response, the joint Australia‑New Zealand Food Regulation System has launched a five‑year National Campylobacter Action Plan, nested within the broader Strategic Action Plan 2025‑2028. The initiative brings together federal and state agencies, FSANZ, the New Zealand Ministry for Primary Industries, industry groups, research institutions, and public‑health bodies. An implementation sub‑committee, co‑led by FSANZ and Safe Food Production Queensland, will draft short‑, medium‑ and long‑term strategies, emphasizing data‑driven risk assessment, improved on‑farm biosecurity, and enhanced processing standards. Open stakeholder registration ensures that producers, retailers, and consumer advocates can shape practical, science‑based measures.

For the food industry, the plan offers a clear regulatory roadmap that could streamline compliance and reduce costly outbreaks. Export markets, increasingly sensitive to food‑safety credentials, are likely to view Australia’s proactive stance as a competitive advantage. Moreover, a successful reduction in campylobacteriosis would alleviate pressure on the healthcare system and generate measurable economic savings. As the plan progresses, its impact will be a barometer for how effectively bi‑national collaboration can tackle entrenched food‑safety challenges.